← Every company
Emergent BioSolutions Inc SEC Filings
What Emergent BioSolutions Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
EBS overview →Filings on file
174
since Sep 30, 2016
Warning signs
3
latest Nov 24, 2023
Last results
Aug 5, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Aug 5, 2026 | Executive or director changeResults announcedRestructuring 8-K | Read ↗ |
| Mar 3, 2026 | Executive or director change 8-K | Read ↗ |
| Nov 12, 2025 | Executive or director change 8-K | Read ↗ |
| Oct 4, 2024 | Executive or director change 8-K | Read ↗ |
| Jul 30, 2024 | Executive or director change 8-K | Read ↗ |
| Jul 12, 2024 | Executive or director change 8-K | Read ↗ |
| May 29, 2024 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Apr 26, 2024 | Executive or director change 8-K | Read ↗ |
| Feb 21, 2024 | Executive or director change 8-K | Read ↗ |
| Oct 2, 2023 | Executive or director change 8-K | Read ↗ |
| Aug 16, 2023 | Executive or director change 8-K | Read ↗ |
| Aug 8, 2023 | Executive or director changeRestructuring 8-K | Read ↗ |
| Jul 27, 2023 | Executive or director change 8-K | Read ↗ |
| Jun 27, 2023 | Executive or director change 8-K | Read ↗ |
| May 31, 2023 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Mar 23, 2023 | Executive or director change 8-K | Read ↗ |
| Jan 9, 2023 | Executive or director changeResults announcedRestructuring 8-K | Read ↗ |
| Jul 6, 2022 | Executive or director change 8-K | Read ↗ |
| Mar 23, 2022 | Executive or director change 8-K | Read ↗ |
| Feb 22, 2022 | Executive or director change 8-K | Read ↗ |
| Jan 14, 2022 | Executive or director change 8-K | Read ↗ |
| Jul 22, 2021 | Executive or director change 8-K | Read ↗ |
| May 25, 2021 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Feb 16, 2021 | Executive or director change 8-K | Read ↗ |
| Aug 26, 2020 | Executive or director change 8-K | Read ↗ |
| May 27, 2020 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Feb 18, 2020 | Executive or director change 8-K | Read ↗ |
| Feb 12, 2019 | Executive or director change 8-K | Read ↗ |
| Jan 24, 2019 | Executive or director change 8-K | Read ↗ |
| Jan 4, 2019 | Executive or director change 8-K | Read ↗ |
| May 24, 2018 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Mar 26, 2018 | Executive or director change 8-K | Read ↗ |
| Feb 14, 2018 | Executive or director change 8-K | Read ↗ |
| Feb 21, 2017 | Executive or director change 8-K | Read ↗ |
| Nov 8, 2016 | Executive or director change 8-K | Read ↗ |
Source: Emergent BioSolutions Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on EBS
Company overviewEverything on EBS in one place, with the price.Insider tradingWhat EBS's own officers and directors buy and sell.Planned salesSales EBS insiders have filed notice of.Who owns itEvery manager reporting a position in EBS.Funds holding itWhich funds and ETFs hold EBS, and how big a bet.LobbyingWhat EBS spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on EBS's account, and who they worked for.Federal contractsWhat federal agencies pay EBS.